Stockreport

Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside [Yahoo! Finance]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF a statistically significant 14.6% higher response rate (49.5%) than those receiving standard of care alone (34.6%) after 48 weeks. In 2024, UCB and Biogen will initiat [Read more]